Cargando…
Platelet phosphorylated TDP-43: an exploratory study for a peripheral surrogate biomarker development for Alzheimer's disease
AIM: Alzheimer's disease (AD) and other forms of dementia create a noncurable disease population in world's societies. To develop a blood-based biomarker is important so that the remedial or disease-altering therapeutic intervention for AD patients would be available at the early stage. MA...
Autores principales: | Wilhite, Rodger, Sage, Jessica M, Bouzid, Abdurrahman, Primavera, Tyler, Agbas, Abdulbaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674277/ https://www.ncbi.nlm.nih.gov/pubmed/29134122 http://dx.doi.org/10.4155/fsoa-2017-0090 |
Ejemplares similares
-
Impaired Cu–Zn Superoxide Dismutase (SOD1) and Calcineurin (Cn) Interaction in ALS: A Presumed Consequence for TDP-43 and Zinc Aggregation in Tg SOD1(G93A) Rodent Spinal Cord Tissue
por: Kim, Jolene M., et al.
Publicado: (2018) -
ADDP and PS-PPh(3): an efficient Mitsunobu protocol for the preparation of pyridine ether PPAR agonists
por: Humphries, Paul S, et al.
Publicado: (2006) -
Regulation of TDP-43 phosphorylation in aging and disease
por: Eck, Randall J., et al.
Publicado: (2021) -
TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021) -
Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis
por: Riva, Nilo, et al.
Publicado: (2022)